Malaysia awards three-year contract for Biocon Biologics’ Insugen
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
Kaiser Permanente finds the Pfizer Covid-19 third dose vaccine protection against hospitalization from omicron wanes after 3 months
A centralised kitchen which provides 5,000 breakfast meals per day is to be started at Perumallapuram, Kakinada, Andhra Pradesh
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
The new facility is scheduled to start operation in the first half of 2024
The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
It paves the way for an industry Code of Good Practice
Ondexxya is the first approved reversal agent specifically for Factor Xa inhibitors, providing a major advance in the treatment of patients hospitalised with life-threatening bleeding
Subscribe To Our Newsletter & Stay Updated